Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 58.37%30.69B | -14.33%19.38B | -12.17%22.62B | 44.90%25.76B | -6.47%17.77B | -10.74%19B | 44.52%21.29B | 19.64%14.73B | -43.71%12.31B | -20.44%21.88B |
Net profit before non-cash adjustment | 14.20%16.26B | 4.20%14.24B | 5.39%13.67B | 19.64%12.97B | 3.73%10.84B | -6.91%10.45B | -8.84%11.23B | -1.83%12.31B | 19.59%12.54B | 5.74%10.49B |
Total adjustment of non-cash items | -13.85%11.85B | 25.85%13.75B | 9.47%10.93B | -9.79%9.98B | 7.99%11.07B | 12.19%10.25B | 7.66%9.13B | -0.48%8.48B | -30.72%8.53B | -11.33%12.31B |
-Depreciation and amortization | 6.54%12.24B | 24.46%11.49B | 6.46%9.23B | -5.58%8.67B | 0.28%9.19B | 0.38%9.16B | 5.81%9.13B | 1.81%8.62B | -26.36%8.47B | 6.07%11.5B |
-Reversal of impairment losses recognized in profit and loss | -67.80%747M | 210.99%2.32B | 177.32%746M | -63.70%269M | -6.32%741M | 394.38%791M | -59.39%160M | 369.05%394M | -5.62%84M | -83.43%89M |
-Share of associates | 4.80%-218M | 11.24%-229M | -163.27%-258M | 63.97%-98M | 13.38%-272M | 1.88%-314M | 16.23%-320M | -28.19%-382M | 3.56%-298M | -0.32%-309M |
-Disposal profit | -88.11%39M | -7.87%328M | 234.85%356M | -375.00%-264M | 81.13%96M | 139.55%53M | 80.88%-134M | -1.45%-701M | -1,051.67%-691M | 31.82%-60M |
-Other non-cash items | -512.74%-962M | -118.45%-157M | -39.34%851M | 6.69%1.4B | 136.09%1.32B | 83.83%557M | -44.81%303M | -42.75%549M | -11.29%959M | -62.60%1.08B |
Changes in working capital | 129.97%2.58B | -336.37%-8.61B | -170.40%-1.97B | 167.88%2.8B | -144.00%-4.13B | -281.85%-1.69B | 115.35%931M | 30.71%-6.07B | -855.68%-8.75B | -124.74%-916M |
-Change in receivables | 51.85%-260M | 93.48%-540M | -41.56%-8.29B | -312.56%-5.85B | 232.92%2.75B | 50.90%-2.07B | 31.47%-4.22B | -261.97%-6.16B | -52.55%3.8B | 248.58%8.01B |
-Change in inventory | 95.25%-384M | -751.68%-8.09B | -137.15%-950M | 210.79%2.56B | 44.14%-2.31B | -3,343.33%-4.13B | 94.79%-120M | -1,919.30%-2.3B | 44.66%-114M | 75.30%-206M |
-Change in payables | -83.74%193M | -89.59%1.19B | 167.85%11.41B | 152.18%4.26B | -403.80%-8.16B | -23.21%2.69B | -33.79%3.5B | 162.08%5.28B | 1.98%-8.51B | -202.21%-8.68B |
-Provision for loans, leases and other losses | -89.01%41M | 109.55%373M | 693.33%178M | -115.63%-30M | -4.95%192M | 60.32%202M | 117.21%126M | -377.27%-732M | 114.63%264M | 164.06%123M |
-Changes in other current assets | 293.91%2.99B | 64.28%-1.54B | -330.65%-4.32B | -44.77%1.87B | 108.93%3.39B | -1.46%1.62B | 179.30%1.65B | 52.18%-2.08B | -2,548.17%-4.34B | -110.07%-164M |
-Changes in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -154.42%-80M | --147M | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -14.50%-529M | -15.79%-462M | 0.25%-399M | 14.35%-400M | -12.26%-467M | 7.56%-416M | 1.53%-450M | -10.39%-457M | 30.07%-414M | 6.92%-592M |
Interest received (cash flow from operating activities) | 21.09%781M | 16.01%645M | 1.83%556M | -21.89%546M | 10.08%699M | 3.25%635M | -13.74%615M | -1.38%713M | 27.96%723M | 1.25%565M |
Tax refund paid | 3.55%-5.92B | -38.97%-6.13B | 4.99%-4.41B | -28.02%-4.65B | -34.16%-3.63B | 58.77%-2.71B | -29.31%-6.56B | -6.24%-5.07B | -14.75%-4.78B | -16.48%-4.16B |
Other operating cash inflow (outflow) | -97.31%6M | 223M | 0 | -96.77%1M | -83.60%31M | -52.99%189M | -15.37%402M | 249.26%475M | -67.62%136M | -20.75%420M |
Operating cash flow | 83.38%25.04B | -25.66%13.65B | -13.61%18.36B | 47.53%21.26B | -13.76%14.41B | 9.22%16.71B | 47.23%15.3B | 30.14%10.39B | -55.91%7.98B | -25.72%18.11B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -6.18%-8.4B | 18.44%-7.91B | -11.64%-9.7B | 29.02%-8.69B | -60.89%-12.25B | -10.82%-7.61B | -12.52%-6.87B | 13.81%-6.1B | -12.32%-7.08B | 44.16%-6.31B |
Net intangibles purchase and sale | -62.96%-352M | 47.95%-216M | 1.19%-415M | 45.10%-420M | -163.79%-765M | -97.28%-290M | 63.97%-147M | 75.14%-408M | -124.49%-1.64B | 76.88%-731M |
Net business purchase and sale | -40,250.00%-807M | 99.98%-2M | -2,769.21%-8.67B | ---302M | ---- | 119.27%430M | -1,367.76%-2.23B | -137.07%-152M | 111.69%410M | -512.04%-3.51B |
Net investment product transactions | 37.50%-25M | -207.69%-40M | 90.37%-13M | -800.00%-135M | -1,400.00%-15M | -102.22%-1M | -99.47%45M | 16,746.00%8.42B | 118.80%50M | 35.90%-266M |
Advance cash and loans provided to other parties | 67.49%-118M | -35.45%-363M | -20.18%-268M | -668.97%-223M | 90.37%-29M | 48.90%-301M | 49.53%-589M | 31.83%-1.17B | -0.47%-1.71B | -204.83%-1.7B |
Repayment of advance payments to other parties and cash income from loans | 102.97%410M | -46.70%202M | 54.07%379M | 72.03%246M | -39.66%143M | -80.62%237M | -10.40%1.22B | 21.44%1.37B | 63.61%1.12B | 40.78%687M |
Net changes in other investments | -70.48%-2.37B | -264.18%-1.39B | 164.24%846M | -33,025.00%-1.32B | -98.07%4M | -89.93%207M | 481.97%2.06B | -105.34%-538M | 44.37%-262M | -192.55%-471M |
Investing cash flow | -19.97%-11.66B | 45.50%-9.72B | -64.54%-17.84B | 16.00%-10.84B | -76.11%-12.91B | -12.55%-7.33B | -558.91%-6.51B | 115.57%1.42B | 25.89%-9.11B | 21.54%-12.3B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -273.46%-2.7B | 197.98%1.56B | -399.37%-1.59B | -107.95%-318M | 364.09%4B | 59.04%-1.52B | -1,931.19%-3.7B | -95.58%202M | 313.19%4.58B | -161.07%-2.15B |
Net common stock issuance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---219M |
Increase or decrease of lease financing | -11.54%-2.21B | -19.94%-1.99B | 14.25%-1.66B | 4.83%-1.93B | -9.86%-2.03B | -10.80%-1.85B | 7.85%-1.67B | -16.20%-1.81B | 54.70%-1.56B | 4.37%-3.44B |
Cash dividends paid | -18.73%-1.48B | -5.87%-1.24B | -16.57%-1.18B | 0.00%-1.01B | -20.00%-1.01B | 0.00%-840M | -25.00%-840M | -33.60%-672M | 0.59%-503M | 12.15%-506M |
Cash dividends for minorities | -18.60%-102M | 22.52%-86M | -50.00%-111M | -2.78%-74M | -30.91%-72M | 3.51%-55M | -16.33%-57M | -40.00%-49M | 74.82%-35M | -32.38%-139M |
Net other fund-raising expenses | 97.37%-3M | -11,300.00%-114M | 0.00%-1M | 50.00%-1M | 0.00%-2M | 96.00%-2M | -4,900.00%-50M | 75.00%-1M | -300.00%-4M | 0.00%-1M |
Financing cash flow | -246.77%-6.5B | 58.65%-1.87B | -36.00%-4.53B | -473.85%-3.33B | 120.93%891M | 32.54%-4.26B | -171.13%-6.31B | -193.98%-2.33B | 138.43%2.48B | -26.49%-6.45B |
Net cash flow | ||||||||||
Beginning cash position | 10.50%42.97B | -7.01%38.88B | 18.65%41.81B | 7.07%35.24B | 18.16%32.91B | 9.35%27.86B | 57.53%25.47B | -6.75%16.17B | 0.09%17.34B | 31.60%17.33B |
Current changes in cash | 234.32%6.88B | 151.36%2.06B | -156.54%-4.01B | 196.11%7.08B | -53.27%2.39B | 107.08%5.12B | -73.92%2.47B | 603.79%9.48B | 312.13%1.35B | -117.59%-635M |
Effect of exchange rate changes | -49.65%1.02B | 88.29%2.03B | 310.16%1.08B | -582.67%-512M | 51.30%-75M | -69.23%-154M | 48.59%-91M | -42.74%-177M | -119.05%-124M | 17.93%651M |
Cash adjustments other than cash changes | ---- | --1M | ---- | ---- | -89.36%10M | --94M | ---- | ---- | ---2.39B | ---- |
End cash Position | 18.38%50.86B | 10.50%42.97B | -7.01%38.88B | 18.65%41.81B | 7.07%35.24B | 18.16%32.91B | 9.35%27.86B | 57.53%25.47B | -6.75%16.17B | 0.09%17.34B |
Free cash flow | 206.97%15.38B | -38.15%5.01B | -32.99%8.1B | 871.38%12.08B | -85.02%1.24B | 10.44%8.3B | 112.43%7.52B | 389.13%3.54B | -111.38%-1.22B | 19.09%10.76B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |